Race Oncology raises $29.7m to fund development of lead anti-cancer drug Zantrene
22:41
ASX:RAC
Watch the video above for detailed insights and analysis.
Video Details
Featured Companies: ASX:RAC
Recorded:
Stay Ahead
Get the latest market insights and analysis delivered to your inbox.